Investing.com - Precigen reported on Wednesday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Precigen announced earnings per share of $-0.040 on revenue of $16.72M. Analysts polled by Investing.com anticipated EPS of $-0.130 on revenue of $2.88M.
Precigen shares are down 19% from the beginning of the year and are trading at $1.470 , down-from-52-week-high.
Precigen follows other major Healthcare sector earnings this month
Precigen's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar